Abstract
For more than a decade, the biological roles and the apparent redundancy of the cytokines tumor necrosis factor (TNF) and lymphotoxin (LT) have been debated. LT alpha exists in its soluble form as a homotrimer, which like TNF only binds the TNF receptors, TNF-R55 or TNF-R75. The cell surface form of LT exists as a heteromer of LT alpha and LT beta subunits and this complex specifically binds the LT beta receptor (LT beta-R). To discriminate the functions of the LT and TNF systems, soluble LT beta-R-immunoglobulin (Ig) or TNF-R-Ig fusion proteins were introduced into embryonic circulation by injecting pregnant mice. Exposure to LT beta-R-Ig during gestation disrupted lymph node development and splenic architecture in the progeny indicating that both effects are mediated by the surface LT alpha/beta complex. These data are the first to identify a cell surface ligand involved in immune organ morphogenesis. Moreover, they unambiguously discriminate the functions of the various TNF/LT ligands, provide a unique model to study compartmentalization of immune responses and illustrate the generic utility of receptor-Ig fusion proteins for dissecting/ordering ontogenetic events in the absence of genetic modifications.
Original language | English |
---|---|
Pages (from-to) | 1999-2006 |
Number of pages | 8 |
Journal | Journal of Experimental Medicine |
Volume | 184 |
Issue number | 5 |
Publication status | Published - 1 Nov 1996 |
Keywords
- Animals
- Cell Membrane/metabolism
- Immunoglobulin G/pharmacology
- Lymph Nodes/embryology
- Lymphoid Tissue/embryology
- Lymphotoxin beta Receptor
- Lymphotoxin-alpha/metabolism
- Membrane Proteins/metabolism
- Mice
- Mice, Inbred BALB C
- Morphogenesis
- Peyer's Patches/embryology
- Receptors, Tumor Necrosis Factor/immunology
- Recombinant Fusion Proteins/pharmacology
- Spleen/embryology
- Tumor Necrosis Factor-alpha/metabolism